CD8A and influenza: This study demonstrated that CW is a promising adjuvant candidate for influenza vaccination owing to its ability to stimulate NK cell activation both in vitro and in vivo, increase NK cell‐mediated cytotoxicity, promote DC maturation, boost CD8+ T cell responses, and enhance the antigen‐specific antibody level in vivo.